The role of cognitive functions in the diagnosis of bipolar disorder: A machine learning model

We caught up with Ercan Altınöz, Associate Professor of Psychiatry at Eskişehir Osmangazi University School of Medicine in Eskişehir, Turkey, who told us how combining CANTAB® tasks with machine learning may help to improve diagnosis of bipolar disorder.  

Using CANTAB to overcome challenges in assessing cognition in people with intellectual disabilities

Operational scientist Eleanor Rist explores how CANTAB™  assessments can be beneficial for studies involving people with intellectual disabilities.

Using CANTAB to assess cognitive function in long-term Hodgkin lymphoma survivors

We caught up with Dr Ferenc Magyari from the University of Debrecen, who told us how CANTABTM has helped them to understand the long-term cognitive impact of Hodgkin’s Lymphoma. 

Emerging technology and other trends from SfN 2022

John Bernstein, Clinical Scientist at Cambridge Cognition, explores the trends and exciting developments that were discussed at the 2022 Society for Neuroscience (SfN) conference.

Four key takeaways from our academic customer survey

In June 2022 we conducted a survey to find out more about what our academic customers think of Cambridge Cognition’s products and services. These surveys are a great opportunity for our customers to give us their honest and candid feedback. We had a great response and gained some very interesting insights and feedback. Here we discuss four of the main points that we learned from the survey. 

2022 CANTAB Research Grant: Examining the relationship between BDNF and Parkinson’s Disease

Amy Tiberio was one of the winners of the 2022 CANTABTM Research Grant. Here she explains more about her project and what winning this grant means for her.

Understanding the effect of ashwagandha root extract on stress, sleep and cognition

We caught up with Shefali Thanawala from Nutriventia Ltd who told us how CANTABTM helped them to investigate the effects of Ashwagandha root extract on memory and focus in healthy, stressed adults. 

Using CANTAB to develop AI-based tools for the early detection of dementia

To mark World Alzheimer's Day, we hear from Christoffer Hatlestad-Hall and his team at Oslo University Hospital, who explain how CANTABTM is an instrumental part of their study using AI and machine learning to identify the earliest signs of Alzheimer's and dementia in people with mild cognitive impairment.

Developing a method of delivering experimenter-led online cognitive assessments

We caught up with Victoria Leong from Nanyang Technological University and University of Cambridge who told us how the COVID-19 pandemic has required a shift to web-based testing and how CANTABTM tasks can be used as part of a rigorous online cognitive testing methodology.  

Using CANTAB to examine antipsychotic use and neurocognition in young people with biploar disorder

We caught up with Xinyue (Joyce) Jiang from the Centre for Addiction and Mental Health in Toronto to hear more about how her team used CANTABTM tasks to understand the effect of antipsychotic medication on cognition in young people affected by bipolar disorder.

Measuring Health-Related Quality of Life with Multimodal Data

In July 2021, I was part of a workshop that discussed how digital measurement of multiple modalities could be used to assess Quality of Life. A paper detailing the findings of the workshop was published in May 2022. The findings are summarised here. 

2022 CANTAB Research Grant winners announced

It has been another highly competitive year for our CANTABTM Research Grant, with the large number of high-quality applications making picking just three winners a challenge for our judging panel! Here we reveal the winning grants.

Using CANTAB to understand the effects of omega-3, carotenoids and vitamin E on cognition

We caught up with Dr Rebecca Power from South East Technological University about how CANTABTM has helped her team to investigate the impact of specific nutrients on cognitive performance.

How CANTAB helps us to explore the cognitive electrophysiology of the deep brain

We caught up with Martin Gillies from the University of Oxford, who told us how CANTABTM tasks help his team to probe the cognitive electrophysiology of the deep brain, particularly focusing on the cognitive role of the dorsal Anterior Cingulate Cortex (dACC) in decision-making. 

Investigating chronic inflammation as a pathway for cognitive dysfunction in depression

PhD Student Naoise Mac Giollabhui received a CANTAB Research Grant in 2018 for his project: ‘Chronic inflammation as a pathway to cognitive dysfunction in adolescents and young adults with a history of elevated depressive symptoms’. CANTAB Research Grants offer up to £1000 to support studies that use at least one Cambridge Cognition cognitive assessment. The 2022 awards are currently open.

We caught up with Naoise to discuss how the grant has benefited his research. 

Hazardous drinking and cognition in schizophrenia, schizoaffective disorder and bipolar disorder

We recently caught up with Atiqul Haq Mazumder, a doctoral researcher at the University of Oulu, Finland. Here, he tells us about how he used CANTAB to understand more about whether hazardous drinking could affect cognition in people with schizophrenia, schizoaffective disorder and bipolar disorder.

Flocking together and thinking apart: Gendered friendships and decision-making in adolescence

We caught up with Professor Eirini Flouri from University College London, to discuss the role CANTAB played in her research into gendered friendships and decision-making in adolescence.

Using CANTAB to identify undiagnosed dementia cases using a web-based pre-screening tool in the MOPE

We recently caught up with Dr. Mercè Boada, the project coordinator of MOPEAD, and Medical Director of Ace Alzheimer Center Barcelona to discuss her recent publication supporting the use of CANTAB for the early detection of undiagnosed people with cognitive impairment.

Fatigue and episodic memory in relapsing-remitting multiple sclerosis: A web-based CANTAB study

Clinical Scientist, Luke Allen, presented on fatigue and episodic memory in relapsing-remitting multiple sclerosis at ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis).

Read on for the key findings and full poster.

Efficient assessment of Emotional Bias using Item Response Theory and Decision Tree Computerised Ada

Director of Research & Innovation, Francesca Cormack, presented on efficient assessment of emotional bias using item response theory and decision tree computerised adaptive testing at the ISCTM Autumn Conference and the 2021 ECNP Congress.

Read on for the key findings and full poster.

Part 1: Your customer journey – Getting to know your research

In part one of our four-part series on the journey our academic customers go through while working with Cambridge Cognition – we focus on our sales team and the work they put in to ensure that we truly understand your research needs. 

Part 2: Your customer journey – Working with Cambridge Cognition

In part two of our four-part series on the journey our academic customers go through while working with Cambridge Cognition – we focus on our Operational Science team and gain some insight into the work they do to help support our academic customers.

Part 4: Your customer journey – Promoting your research

In the final instalment of our four-part series on the journey our academic customers go through while working with Cambridge Cognition – we focus on our Marketing team and the work they put in to support and promote your research. 

Part 3: Your customer journey – Supporting your study

In part three of our four-part series on the journey our academic customers go through while working with Cambridge Cognition – we focus on our Customer Support and Logistics teams, diving into the work they do to help launch and support your study.

Targeting adolescent neurocognitive processes in depression to promote intervention response

Florin Tibu from the Department of Health and Human Development at the Stefan cel Mare University of Suceava recently gave us an insight into how CANTAB has impacted his research into targeting adolescent neurocognitive processes in depression to promote intervention response.

The international ENIGMA II substudy on postoperative cognitive disorders

We caught up with Dr. Guy Haller from Geneva University Hospital, to discuss the role CANTAB played in the international ENIGMA II substudy on postoperative cognitive disorders (ISEP)

Using CANTAB to understand the role of cognitive control and rumination in predicting depression amo

We recently caught up with Sanja Jandric, from the University of Osijek to discuss her research into the role of cognitive control and rumination in predicting depression among adolescents with internalising disorders.

Investigating the role of cognitive reserve in cognitive ageing

We recently caught up with Insa Feinkohl from the BioCog Consortium, to discuss the research they’ve been conducting, focusing on investigating the role of cognitive reserve in cognitive ageing.

Using CANTAB to compare the effects of augmented reality N-back training and traditional two-dimensi

We recently caught up with Dr Bo Zhang from East China Normal University to discuss her research: A Comparison of the Effects of Augmented Reality N-Back Training and Traditional Two-Dimensional N-Back Training on Working Memory

COVID-19 Cognitive Assessment Battery

To understand the impact of COVID-19 on cognitive function, researchers must use sensitive and reliable cognitive assessments which target appropriate domains. In this article Operational Scientist, Iona Pickett, discusses the challenges of designing a cognitive testing battery for use in those recovering from COVID-19 and describes our recommended CANTAB battery for COVID-19 studies.